SEC Form 4 · accession 0001209191-15-015145
BIOCEPT INC · BIOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Margaret Faye Wilson
Director
Period of report
Feb 13, 2015
Accepted (ET)
Feb 18, 2015 · 2:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 13, 2015 | P | 4,000 | $1.25 | A | 9,074 | D | |
| Common Stock | holding | — | — | — | 1,417 | I | By LLC | |
| Common Stock | holding | — | — | — | 2,374 | I | By Reporting Person's retirement account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to Purchase Common StockF1 | $1.56 | Feb 13, 2015 | P | 4,000 | A | Feb 13, 2015 | Feb 13, 2020 | Common Stock | 4,000 | 4,000 | D |
Explanation of responses
- F1Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.25 per unit.